Editas Medicine (EDIT)
2.56
+0.05 (1.99%)
Upcoming Events
Latest Headlines
Editas Medicine to present LNP research at ESGCT congress in October
October 14, 2026 9:01 AM - StreetInsider
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
October 14, 2026 9:00 AM - StreetInsider
Wells Fargo Upgrades Editas Medicine (EDIT) to Equal Weight
October 8, 2026 12:19 PM - StreetInsider
Form 8-K Editas Medicine, Inc. For: Oct 08
October 8, 2026 7:05 AM - SEC Filing
Editas Medicine clears first-in-human trial of EDIT-401 in Australia
October 8, 2026 7:01 AM - StreetInsider
Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia
October 8, 2026 7:00 AM - StreetInsider
Guggenheim Upgrades Editas Medicine (EDIT) to Buy
September 23, 2026 6:05 AM - StreetInsider
Editas Medicine grants stock options to new chief medical officer
September 9, 2026 9:00 AM - StreetInsider
Editas Medicine Reports Inducement Grants to New Chief Medical Officer
September 9, 2026 9:00 AM - StreetInsider
Editas Medicine names Dan Ory as chief medical officer
September 8, 2026 7:00 AM - StreetInsider
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
September 8, 2026 7:00 AM - StreetInsider
Editas Medicine to Participate in Upcoming Investor Conferences
September 1, 2026 9:00 AM - StreetInsider
Ladenburg Thalmann Starts Editas Medicine (EDIT) at Buy
August 18, 2026 6:35 AM - StreetInsider
Form SCHEDULE 13G Editas Medicine, Inc. Filed by: ADAR1 Capital Management, LLC
August 14, 2026 9:30 PM - SEC Filing
Form 4 Editas Medicine, Inc. For: Aug 06 Filed by: Ellinor Patrick Thomas II
August 7, 2026 5:16 PM - SEC Filing
Form 3 Editas Medicine, Inc. For: Aug 06 Filed by: Ellinor Patrick Thomas II
August 7, 2026 5:16 PM - SEC Filing
Editas Medicine (EDIT) Tops Q2 EPS by 12c
August 5, 2026 4:45 PM - StreetInsider
Form 4 Editas Medicine, Inc. For: Aug 03 Filed by: Parison Amy
August 5, 2026 4:11 PM - SEC Filing
Form 10-Q Editas Medicine, Inc. For: Jun 30
August 5, 2026 4:06 PM - SEC Filing
Form 8-K Editas Medicine, Inc. For: Aug 03
August 5, 2026 4:03 PM - SEC Filing
Editas Medicine Announces Second Quarter 2026 Results and Business Updates
August 5, 2026 4:01 PM - StreetInsider
Editas Medicine adds cardiovascular geneticist to its board
August 4, 2026 4:15 PM - StreetInsider
Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.D., Ph.D.
August 4, 2026 4:15 PM - StreetInsider
Form 4 Editas Medicine, Inc. For: Jul 28 Filed by: Burkly Linda
July 29, 2026 4:51 PM - SEC Filing
Form SCHEDULE 13G/A Editas Medicine, Inc. Filed by: BlackRock, Inc.
July 29, 2026 3:20 PM - SEC Filing
Full Article List
